There is a lot to like here, low market cap, good share structure, low debt, highly speculative telehealth medical device field, so rather than try to predict when exactly a noteholder will convert or when the company will release big news, I wouldnt want to risk missing it so I will be here holding.
Having said that, I do think they need to start releasing news regularly again like they historically have.. but I think the opportunity here is too good to pass up